Filing Details
- Accession Number:
- 0001455244-11-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-05 17:25:42
- Reporting Period:
- 2011-04-01
- Filing Date:
- 2011-04-05
- Accepted Time:
- 2011-04-05 17:25:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271999 | F E Raafat Fahim | C/O Nabi Biopharmaceuticals 12276 Wilkins Ave Rockville MD 20852 | President, Ceo And Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-31 | 3,096 | $4.20 | 333,734 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 3,023 | $4.30 | 336,757 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2011-04-01 | 50,000 | $0.00 | 386,757 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2011-04-05 | 13,283 | $5.76 | 373,474 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 5 | J | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2011-04-01 | 150,000 | $0.00 | 150,000 | $5.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 150,000 | 2018-04-01 | No | 4 | A | Direct |
Footnotes
- Voluntarily reported acquisition under the Issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3.
- Restricted Stock which vests in four equal annual installments beginning on April 1, 2012.
- This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
- This Option will become exercisable in four equal annual installments beginning on April 1, 2012.
Billionaire Hedge Funds
